@mozz"Matt and Scott are supreme forces in themselves...the deals and operations these guys have put together in the past..."
Can you provide specific and relevant successful examples here?
"The DD they have done and are doing..."
How does doing DD translate into success for PAR?
"They have the skill set to turn us around"
Do either/ both have experience in ECM, clinical trials or negotiating pharma deals?To all...Anyone have thoughts on why bio's have rebounded from lows globally including in Australia (IMU, RAC, OPT etc...) Yet PAR languishes....?
General OA media and info, page-614
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $92.81M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 29.0¢ | 25.5¢ | $430.3K | 1.585M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5500 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 36162 | 3 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |